Roche CAT 05910412190

Ended Awarded Last action

Contract number
N0018923F0800
Awardee
Awarding agency
Obligated
-$512

Award facts

Opportunity
Contract value 0% obligated
$1,000,742.33 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Bureau of Medicine and Surgery Department of the Navy, Department of Defense
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 -$512
Original award $1,001,254

About this award

The U.S. Navy's Bureau of Medicine and Surgery awarded a $1.0 million firm fixed-price delivery order to Roche Diagnostics Corporation on September 29, 2023, with an ultimate completion date of September 30, 2024. This child delivery order, which carries no set-aside designation, reflects open competition and is performed at Roche's facility in Castleton, Indiana. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, specializes in in vitro diagnostics, laboratory instruments, reagents, and associated medical products serving federal healthcare agencies, particularly the Department of Defense and Department of Veterans Affairs.

The contract represents a portion of Roche's extensive federal diagnostic contracting portfolio, which includes multiple indefinite delivery contracts and blanket purchase agreements with various Veterans Integrated Service Networks and Defense Health Agency entities. These vehicles support critical laboratory testing capabilities across military and veterans healthcare systems, encompassing molecular diagnostics, clinical chemistry analysis, immunochemistry testing, histology services, and point-of-care testing platforms. Roche maintains established General Services Administration schedule contracts under the Critical Analyzers, Laboratory and In Vitro Diagnostics, Reagents, Test schedules, enabling efficient procurement of diagnostic technologies and consumables across federal healthcare networks through pre-negotiated pricing structures.

Quick answers

Who was awarded contract N0018923F0800?

N0018923F0800 was awarded to Roche Diagnostics Corporation by Naval Supply Systems Command (Department of the Navy) on September 29, 2023.

How much is contract N0018923F0800 worth?

The government has obligated -$512 on N0018923F0800. Its current value, with exercised options, is $1,000,742.

Which agency awarded contract N0018923F0800?

Naval Supply Systems Command (Department of the Navy) awarded N0018923F0800, with funding from Bureau of Medicine and Surgery (Department of the Navy).

Is contract N0018923F0800 an order under another contract?

Yes. N0018923F0800 is a delivery order under N0018923D0042, an indefinite delivery contract.

Was contract N0018923F0800 competed?

The extent of competition for N0018923F0800 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award